McKesson extends CVS deal as Argus raises McKesson stock target

Published on 10/07/2026 at 14:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Argus raised its target to USD 970.00 on September 3, 2026. McKesson stock costs EUR 822.40 on October 7, 2026 after EUR 821.60, plus 0.10 percent.

Mitarbeiter sortieren unbeschriftete Pakete in einem großen Pharma-Logistiklager mit Regalen — Fotorealistisches Bild zeigt McKesson Corporation ISIN US58155Q1031 als Pharmagroßhändler in modernem Distributionslager mit vielen Mitarbeitern, Illustration mit AI erstellt.

McKesson (US58155Q1031) was at EUR 822.40 at Lang & Schwarz on October 7, 2026 at 2:43 p.m. CEST, up EUR 0.80 or 0.10 percent versus the prior close of EUR 821.60. On October 1, 2026, McKesson announced an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032. The headline adds an analyst angle: MarketScreener reported on September 3, 2026, that Argus raised its McKesson target from USD 850.00 to USD 970.00.

CVS agreement runs to June 2032

The agreement covers deliveries to CVS Health mail-order and specialty pharmacies, retail pharmacies and distribution centers. The companies have worked together for more than 25 years, according to the October 1, 2026 release.

The arrangement remains an agreement in principle rather than a final contract. McKesson identified two risks in the release: negotiations could delay a definitive contract, or the parties could fail to sign one.

Guidance stays at USD 44.20-45.00

McKesson reaffirmed fiscal 2027 adjusted earnings per share guidance of USD 44.20-45.00 on October 1, 2026. It also maintained a long-term adjusted earnings per share growth target of 13.00-16.00 percent, figures reported by McKesson.

The next scheduled update is the second-quarter fiscal 2027 earnings call on November 4, 2026. The latest reported first quarter produced USD 105.4 billion of revenue, up 8.00 percent year over year, while adjusted earnings per share rose 20.00 percent to USD 9.93, according to Ticker Scout in its filing summary.

Euro quote holds above prior close

At Lang & Schwarz, McKesson was trading at EUR 822.40 on October 7, 2026 at 2:43 p.m. CEST, plus 0.10 percent versus the prior close of EUR 821.60. The primary listing is NYSE, where the stock was last at USD 921.67 on October 6, 2026 at 4:00 p.m. EDT; market capitalization was USD 107.9 billion, with a 52-week range of USD 723.68-999.00 as of that quote.

The further course of trading is shown by the continuously updated real-time quote of McKesson stock.